IPPC:an interactive platform for prostate cancer multi-omics data integration and analysis  

作　　者：Xiongjun Ye Fujun Peng Jun Liu Haiyue Zhao Weinan Chen Huanrui Wang Peng Zhang Xiaobo Huang 

机构地区：[1]Urology and Lithotripsy Center,Peking University People’s Hospital,Beijing 100034,China [2]Center for Systems Medicine,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China [3]Suzhou Institute of Systems Medicine,Chinese Academy of Medical Sciences,Suzhou 215123,China [4]University of Maryland School of Medicine,Baltimore,MD 21201,USA

出　　处：《Journal of Molecular Cell Biology》2021年第5期383-385,共3页分子细胞生物学报（英文版）

基　　金：This research was supported by the Center for Health Statistics and Information,National Health Commission of China(2127000141).

摘　　要：Prostate cancer is a clinically heterogeneous disease and remains the most common non-skin malignancy in men worldwide(Abate-Shen and Shen,2000;Litwin and Tan,2017),which is often diagnosed through screening with digital rectal examinations and quantitation of serum levels of prostate-specific antigen(PSA).At the morphological aspect,the Gleason scoring system is regarded as the most reliable and predictive histo-logical grading system(Welch and Albertsen,2009;Heidenreich et al.,2011).

关 键 词：cancer INTERACTIVE integration 

分 类 号：R737.25[医药卫生—肿瘤]